Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2008-07-15
2008-07-15
Pak, Michael (Department: 1646)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S004000, C435S007200, C435S007320
Reexamination Certificate
active
07399602
ABSTRACT:
Method of diagnosing and/or prognosticating HIV infection in a subject comprising the steps of: (a) performing in vitro a measurement of the level of a marker in the form of (i) urokinase plasminogen activator receptor (uPAR), (ii) soluble urokinase plasminogen activator receptor (suPAR), (iii) urokinase-type plasminogen activator (uPA), (iv) one or more degradation products of (i), (ii) or (iii), and/or (v) an mRNA for (i), (ii) or (iii), in a biological fluid sample from a subject, and (b) using the measurement value obtained to evaluate the state of the subject.
REFERENCES:
patent: 4845026 (1989-07-01), Kung et al.
patent: 5459078 (1995-10-01), Kline et al.
patent: 2318740 (1999-07-01), None
patent: 2384295 (2000-11-01), None
patent: 19840671 (2000-03-01), None
patent: WO-01/38871 (2001-05-01), None
Nykjaer, Anders, et al., “Urokinase Receptor, An Activation Antigen in Human T Lymphocytes”, Journal of Immunology, 1994, vol. 152, pp. 505-516.
Speth, Cornelia, et al., “Urokinase Plasminogen Activator Receptor (uPAR; CD87) Expression on Monocytic Cells and T Cells is Modulated by HIV-1 Infection,” Immunobiology, 1998, vol. 199, pp. 152-162.
Mustjoki, Satu, et al., “Soluble Urokinase Receptor Levels Correlate with Number of Circulating Tumor Cells in Acute Myeloid Leukemia and Decrease Rapidity during Chemotherapy”, Cancer Research, Dec. 15, 2000, vol. 60, pp. 7126-7132.
Rha, Sun Young, et al., “Correlation of tissue and blood plasminogen activation system in breast cancer,” Cancer Letters, 2000, vol. 150, pp. 137-145.
Hengge, Ulrich R., et al., “Randomized, controlled phase II trial of subcutaneous interleukin-2 in combincation with highly active antiretroviral therapy (HAART) in HIV patients”, AIDS, 1998, vol. 12, No. 17, pp. F225-F234.
Stephens, Ross W., et al., “ELISA determination of soluble urokinase receptor in blood from healthy donors and cancer patients”, Clinical Chemistry, 1997, vol. 43, No. 10, pp. 1868-1876.
Apr. 23, 2001 International Search Report issued during prosecution of PCT/DK00/00651.
Dekkers, Pascale E.P., et al., “Upregulation of Monocyte Urokinase plasminogen Activator Receptor during Human Endotoxemia”, Infection and Immunity, vol. 68, No. 4, Apr. 2000, pp. 2156-2160.
Coleman, James L., et al. “Borrelia burgdorferiand Other Bacterial Products Induce Expression and Release of the Urokinase Receptor (CD87)1”, The Journal of Immunology, vol. 166, 2001, pp. 473-480.
Florquin, et al., “Release of urokinase plasminogen activator receptor during urosepsis and endotoxemia”, Kidney International, vol. 59, 2001, pp. 2054-2061.
Fauser, Susanne, et al., “Lesion associated expression of urokinase-type plasminogen activator receptor (uPAR, CD87) in human cerebral malaria”, Journal of Neuroimmunology, vol. 111, 2000, pp. 234-240.
Heegaard, C.W., et al., “Plasminogen Activators in Bovine Milk During Mastitis, an Inflammatory Disease”, Fibrinolysis, vol. 8, 1994, pp. 22-30.
Todd, Robert F., et al., “Bacterial lipopolysaccharide, phorbol myristate acetate, and muramyl dipeptide stimulate the expression of a human monocyte surface antigen”, The Journal of Immunology, vol. 135, No. 6, Dec. 1985, pp. 3869-3877.
Eugene-Olsen, J., et al., “The serum level of soluble urokinase receptor is elevated in tuberculosis patients and predicts mortality during treatment: a community study from Guinea-Bissau” Int. K. Tuberc. Lung Dis., vol. 6, No. 8, 2002, pp. 686-692.
Juffermans, Nicole P., et al., “Concurrent Upregulation of Urokinase Plasminogen Activator Receptor and CD11b during Tuberculosis and Experimental Endotoxemia”, Infection and Immunity, vol. 69, No. 8, 2001, pp. 5182-5185.
Garcia-Monco, Juan Carlos, et al., “Soluble urokinase receptor (uPAR, CD 87) is present in serum and cerebrospinal fluid in patients with neurologic diseases”, Journal of Neuroimmunology, vol. 129, 2002, pp. 216-223.
Indian Patent Office First Examination Report.
Darby & Darby P.C.
Pak Michael
ViroGates A/S
LandOfFree
Method of prognosticating respiratory bacterial infection... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of prognosticating respiratory bacterial infection..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of prognosticating respiratory bacterial infection... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2778621